15-253
Showing 1 - 25 of >10,000
Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in
Terminated
- Acute Myelogenous Leukemia in Relapse
- +4 more
-
Tucson, Arizona
- +12 more
Aug 18, 2022
No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and
Recruiting
- Colorectal Cancer
- Lymph Node Metastasis
- Laparoscopic colorectal surgery
-
Beijing, Beijing, China
- +3 more
Nov 16, 2023
Iron Deficiency Anemia Trial in Waltham (Ferumoxytol)
Terminated
- Iron Deficiency Anemia
-
Waltham, MassachusettsAMAG Pharmaceuticals, Inc.
Mar 31, 2022
Rectal Cancer Trial in Beijing, Shanghai, Chengdu (Dissection of the No.253 lymph node, Omitting the dissection of the No.253
Not yet recruiting
- Rectal Cancer
- Dissection of the No.253 lymph node
- Omitting the dissection of the No.253 lymph node
-
Beijing, Beijing, China
- +6 more
Nov 27, 2023
Migraine Headache Trial in United States (DFN-15 Active, DFN-15 Placebo)
Completed
- Migraine Headache
- DFN-15 Active
- DFN-15 Placebo
-
Birmingham, Alabama
- +42 more
Dec 15, 2022
Fluorescence, Indocyanine Green, Rectal Cancer Surgery Trial in Beijing (Fluorescence laparoscopic system)
Recruiting
- Fluorescence
- +2 more
- Fluorescence laparoscopic system
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Sep 10, 2023
Terminal Illness, Terminal Cancer Trial in Zürich (music therapy, recording)
Not yet recruiting
- Terminal Illness
- Terminal Cancer
- music therapy
- recording
-
Zürich, ZH, SwitzerlandUniversity Hospital Zurich
Oct 24, 2023
Alzheimer, Dementia, Brain Diseases Trial in Worldwide (Donanemab, Placebo)
Not yet recruiting
- Alzheimer Disease
- +8 more
- Donanemab
- Placebo
-
Brussels, Bruxelles-Capitale, Région De, Belgium
- +147 more
Aug 18, 2022
Alpha 1-Antitrypsin Deficiency Trial in Worldwide (belcesiran, Placebo)
Recruiting
- Alpha 1-Antitrypsin Deficiency
- belcesiran
- Placebo
-
Melbourne, Australia
- +15 more
Aug 10, 2022
Paroxysmal Nocturnal Hemoglobinuria, PNH Trial in Worldwide (Ravulizumab)
Completed
- Paroxysmal Nocturnal Hemoglobinuria
- PNH
- Ravulizumab
-
Toronto, Ontario, Canada
- +15 more
Dec 7, 2022
Stress, Anxiety, Depressive Symptoms Trial in Ankara (Mindfulness-based stress reduction group, Cognitive behavioral-based
Completed
- Stress
- +2 more
- Mindfulness-based stress reduction group
- Cognitive behavioral-based stress reduction group
-
Ankara, TurkeyAyşegül Yay Pençe
Nov 27, 2023
Efficacy, Safety, Pharmacokinetics Trial in Jilin (Hepenofovir Fumarate Tablets)
Recruiting
- Efficacy
- +2 more
- Hepenofovir Fumarate Tablets
-
Jilin, Changchun, ChinaThe First Hospital of Jilin University
Nov 2, 2023
Attention Deficit Disorder With Hyperactivity Trial in Taipei city (Garmin Vivosmart wearable device)
Enrolling by invitation
- Attention Deficit Disorder With Hyperactivity
- Garmin Vivosmart wearable device
-
Taipei city, TaiwanNational Taiwan University Hospital
Mar 31, 2023
Tuberculosis, Diagnostics, Global Health Trial in Maputo, Cape Town, Kampala (Oral swab molecular testing, Automated Cough Sound
Not yet recruiting
- Tuberculosis
- +2 more
- Oral swab molecular testing
- +3 more
-
Maputo, Mozambique
- +2 more
Aug 9, 2023
Refractory Tumor, Solid Tumor Trial in Kaohsiung, Tainan (Dendritic Cell Vaccine, Lenvatinib, Nivolumab)
Not yet recruiting
- Refractory Tumor
- Solid Tumor
- Dendritic Cell Vaccine
- +2 more
-
Kaohsiung, Taiwan
- +2 more
Mar 2, 2023
Postpartum Sepsis, Postpartum Endometritis, Postpartum Fever Trial in Bamenda (Azithromycin, Azithromycin and amoxicillin,
Completed
- Postpartum Sepsis
- +2 more
- Azithromycin
- +2 more
-
Bamenda, CameroonCameroon Baptist Convention Health Services
Mar 18, 2022
Solid Tumor, Adult Trial in Germany, Spain, Switzerland (CTL-002)
Recruiting
- Solid Tumor, Adult
- CTL-002
-
Essen, Germany
- +5 more
Mar 2, 2022
Locally Advanced/Metastatic Solid Tumors Trial in United States (BJ-001, Pembrolizumab)
Recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Saint Louis, Missouri
- +4 more
Jun 5, 2022
Rheumatoid Arthritis Trial in Worldwide (Apremilast 30 mg, Apremilast 20 mg, Placebo)
Terminated
- Rheumatoid Arthritis
- Apremilast 30 mg
- +2 more
-
Gilbert, Arizona
- +49 more
Apr 22, 2020
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in United States (Nivolumab, Stereotactic Body Radiation Therapy (SBRT))
Completed
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Nivolumab
- Stereotactic Body Radiation Therapy (SBRT)
-
Basking Ridge, New Jersey
- +5 more
Feb 15, 2022